Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study
暂无分享,去创建一个
L. Tian | H. Uno | M. Pfeffer | Lee-Jen Wei | L. J. Wei | F. Jiang | Lu Tian | T. Hasegawa | Fei Jiang | Takahiro Hasegawa
[1] H. Uno,et al. Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies. , 2015, Annals of internal medicine.
[2] Cun-Hui Zhang,et al. Lasso adjustments of treatment effect estimates in randomized experiments , 2015, Proceedings of the National Academy of Sciences.
[3] Yoshiaki Uyama,et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Luke W. Miratrix,et al. Adjusting treatment effect estimates by post‐stratification in randomized experiments , 2013 .
[5] D. Mehrotra,et al. An efficient alternative to the stratified Cox model analysis , 2012, Statistics in medicine.
[6] Lihui Zhao,et al. On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial. , 2012, Biostatistics.
[7] Michael Rosenblum,et al. Targeted Maximum Likelihood Estimation of the Parameter of a Marginal Structural Model , 2010, The international journal of biostatistics.
[8] M J van der Laan,et al. Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation , 2009, Statistics in medicine.
[9] M. Davidian,et al. Covariate adjustment for two‐sample treatment comparisons in randomized clinical trials: A principled yet flexible approach , 2008, Statistics in medicine.
[10] Marie Davidian,et al. Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates , 2008, Biometrics.
[11] D. Fraser. Ancillaries and Conditional Inference , 2004 .
[12] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[13] S. Pocock,et al. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.
[14] Ji Zhang,et al. Analysis of Data with Imbalance in the Baseline Outcome Variable for Randomized Clinical Trials , 2001 .
[15] G G Koch,et al. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. , 1998, Statistics in medicine.
[16] Richard Valliant,et al. Poststratification and Conditional Variance Estimation , 1993 .
[17] S J Senn,et al. Covariate imbalance and random allocation in clinical trials. , 1989, Statistics in medicine.
[18] John D. Kalbfleisch,et al. Sufficiency and conditionality , 1975 .
[19] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[20] D.,et al. Regression Models and Life-Tables , 2022 .